ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AEN Adeona Pharmaceuticals Common Stock

0.00
0.00 (0.00%)
Pre Market
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Adeona Pharmaceuticals Common Stock AMEX:AEN AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Adeona to Present at the 12th Annual Rodman & Renshaw Healthcare Conference

10/09/2010 11:00am

PR Newswire (US)


Adeona Pharmaceuticals Common Stock (AMEX:AEN)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Adeona Pharmaceuticals Common Stock Charts.

ANN ARBOR, Mich., Sept. 10 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (Amex: AEN) announced today that it will present at the 12th Annual Rodman and Renshaw Healthcare Conference. The conference will be held September 12th to 15th at The New York Palace Hotel in New York, NY. Dr. James S. Kuo, Adeona's Chief Executive Officer, will provide an update on the Company's clinical trials on Wednesday, September 15th, at 10:50 am EDT in the Fahnestock Salon (5th Floor).  

A live webcast of Adeona's presentation can be accessed by logging onto http://www.wsw.com/webcast/rrshq18/aen/  or by going to Adeona's website at www.adeonapharma.com. A replay of the presentation will be archived for 90 days at the same sites.

About Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases.  Our primary strategy is to license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to a valuation inflection point resulting in a significant development and marketing collaboration. We have four drug candidates and one medical food candidate in development. Further information on the company is available at www.adeonapharma.com.

SOURCE Adeona Pharmaceuticals, Inc.

Copyright . 10 PR Newswire

1 Year Adeona Pharmaceuticals Common Stock Chart

1 Year Adeona Pharmaceuticals Common Stock Chart

1 Month Adeona Pharmaceuticals Common Stock Chart

1 Month Adeona Pharmaceuticals Common Stock Chart

Your Recent History

Delayed Upgrade Clock